Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 15 of 20
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NCT01612169
Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL)
NCT01657331
Study of Erlotinib and Metformin in Triple Negative Breast Cancer
NCT01650506
Connect 'n Unite: Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM
NCT01394900
Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients
NCT01645787
Optical Tomographic Imaging of Infantile Hemangiomas
NCT01673971
Women Initiating New Goals of Safety
NCT01788579
Using mTOR Inhibitors in the Prevention of BK Nephropathy
NCT01649609
A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers
NCT01659554
Effects of Symbicort on the Ventilatory Kinematics
NCT01712854
Ketamine in the Treatment of Depression
NCT01558063
Effects of Transfusion of Older Stored Red Cells
NCT01534676
Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children
NCT01549002
Denosumab in Primary Hyperparathyroidism
NCT01558115
S. Aureus Colonization in Atopic Dermatitis
NCT02091037
Giant Axonal Neuropathy Natural History Study
NCT01503125
FeverText: Assessing Fever Rates After Vaccination During the 2011-12 Influenza Season Using Text Messaging
NCT01467934
Prognosis of Very Low Dose SPECT
NCT01387152
Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia After Cesarean Section
NCT01465191
Traumatic Brain Injury - Knowledge Translation
NCT01453621
Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure
NCT01534663
The Impact of Early Feeding After Radical Cystectomy for Bladder Cancer
NCT01489800
RHYTHM (Formerly Escape II Myocardium)
NCT01548768
Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral Feeding Formula Versus a Standard Formula In Multiple Intensive Care Unit Settings
NCT01448135
Vitamin D Repletion in Primary Hyperparathyroidism
NCT01306656
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
NCT01470183
Annular Array Ultrasound in Ophthalmology
NCT01415037
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
NCT02500147
Medication Adherence in Individuals With Epilepsy
NCT01566500
Intralesional Steroids in the Treatment of Alopecia Areata
NCT01898806
Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
NCT01403142
Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users
NCT02362373
Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate Surgery
NCT01794936
Seek, Test, and Retain. Linkages for Black HIV+, Substance-Using MSM
NCT01790360
Evoked Retinal Response
NCT01415453
Pharmacodynamics of Nasal and Buccal Midazolam Using EEG
NCT01316445
Text Message Reminder-Recalls For Early Childhood Vaccination
NCT01199666
A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy Pain
NCT01288937
Robotic and Conventional Hand Therapy After Stroke
NCT03020576
Environmental Intervention Versus Standard Care to Reduce Pharmacologic Therapy for Asthma
NCT01593111
Cardiovascular and Neurohormonal Effects of Faster Atrial Pacing Rate
NCT00698139
Effect of Intervention to Improve Stroke Recognition
NCT01497886
Northern Manhattan Caregiver Intervention Project
NCT01306695
High-Tc Susceptometer to Monitor Transfusional Iron Overload
NCT01241357
Decreasing Medication Errors by Caregivers Using a Health Literacy Intervention
NCT01294501
Use of PET-CT in the Management of Crohn's Disease
NCT01182467
Measuring Adherence to Control Hypertension
NCT01257347
Cytokine Production and Immunity to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster Vaccine
NCT01288014
Cook for Your Life!: Implementing Dietary Change Among Hispanic Breast Cancer Survivors
NCT01414062
Vitamin D HIV Study on Postmenopausal Women
NCT01375010
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Columbia University pipeline card: 958 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.